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ABSTRACT
Objective: The objective of this study is to review our
experience of shunt surgery by investigating 40 years
of development in terms of rates of revision and
infection, shunt survival and risk factors.
Design and participants: Medical records and
operative reports were reviewed retrospectively for all
patients who underwent primary shunt surgery at our
department in the years 2010 to 2012. All results were
compared with a previous study from our department.
A mixed population consisting of 434 patients was
included. Adults (≥15 years) accounted for 89.9% of
all patients and the mean follow-up time was
1.71 years.
Results: Overall, 42.6% had a revision of which
65.4% fell within 6 months postoperatively. Low age,
high-risk diagnoses and less severe brain injury were
associated with a higher risk of revision. One and
5-year shunt survival probabilities were 66.2%
(61.5–70.9) and 48.0% (41.1–54.9). Within 4 weeks
postoperatively, 3.2% had an infection and overall
infection rate was 5.5%. Short duration of surgery and
the use of antibiotic prophylaxis were associated with a
lower risk of infection. The most frequent causes of
revision were valve defects (18.4%) and proximal
defects or obstructions (15.7%). Compared to the
previous study, no convincing improvement was found
with regard to the revision rate (42.6% vs 48.3%,
p 0.060) or overall infection rate (5.5% vs 7.4%,
p 0.261).
Conclusions: Regardless of changes in patient
demographics, techniques and equipment, risk of
revision and infection still constitutes a major challenge
in shunt surgery. The absence of convincing
improvements calls for more studies concerning
strategies to reduce complications.
INTRODUCTION
Shunting of the cerebrospinal ﬂuid (CSF)
remains the treatment of choice for the
majority of patients with hydrocephalus.
Shunting of the CSF provides an immediate
and effective treatment necessary to avoid
the resulting neurological damage if the con-
dition is left untreated. Unfortunately, shunt
surgery is associated with an excessive rate of
complications. For each patient this is
reﬂected in the high risk of experiencing
one or more reoperations. Together with the
high incidence of hydrocephalus the treat-
ment constitutes a signiﬁcant medical and
economic problem.1 At our department
shunt-related surgery constitutes 14.1% of all
neurosurgical procedures with primary inser-
tions accounting for less than half of these.
Therefore, it is a proclaimed goal to reduce
the incidence of shunt revisions.
In 1995 and 1998 Borgbjerg et al2–4
published three papers emanating from
our department concerning patients with
primary shunt surgery from the period 1958
to 1989. Since then, several similar retro-
spective studies have reported comparable
results according to rates of revision and
Strengths and limitations of this study
▪ This is one of only very few studies concerning
developments in outcomes for a mixed group of
shunted patients reflecting the changing demo-
graphics over such a long period of time.
▪ In the attempt to make the new cohort compar-
able to the historic cohort, some definitions do
not fit with a modern classification of patients
with hydrocephalus.
▪ Since the objective was to compare the overall
outcome for the entire group of shunted patients
at different times, we omitted to exclude the few
patients with ventriculoatrial-shunts and the rela-
tively small number of children resulting in a het-
erogeneous group with subsequent limitations
for the study conclusions.
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infection, patient speciﬁc and intraoperative risk factors,
and causes of shunt failure.5–12 Other studies have inves-
tigated the beneﬁts of applying different procedural
strategies13–15 and the use of speciﬁc shunt hardware to
avoid certain complications in high-risk patients.16–18
Conversely, only few studies have addressed whether
shunt surgery has improved over the past few decades
resulting in decreased revision rates and prolonged
shunt survival. Most of these studies conclude this does
not seem to be the case19–21 while one study describes
better outcomes for recently shunt-treated paediatric
patients.22
The purpose of the present study is to evaluate trends
in shunt surgery over decades by using two data sets gen-
erated in our department. This is achieved by compar-
ing the published cohort 1958–1989 to a new group of
patients with shunt surgery between 2010 and 12 in
terms of (1) the rate of revision and risk factors for revi-
sion; (2) the rate of infection and risk factors for infec-
tion; (3) shunt survival time; and (4) frequent causes of
shunt failure. Thus we have chosen the same parameters
and largely the same statistics to facilitate comparison
between the two cohorts.
METHODS AND MATERIALS
One author retrospectively reviewed the medical records
and operative reports for all patients who underwent
shunt surgery for hydrocephalus and related conditions
at the Department of Neurosurgery, Rigshospitalet in
the 3-year period between 1 January 2010 and 31
December 2012 with further 2 years of follow-up until 31
December 2014. If in the least doubt, the cause of revi-
sion was double-checked by a neurosurgeon blind to the
procedure method and surgeon.
The Department of Neurosurgery at the University
Hospital Rigshospitalet is the largest of four neurosurgi-
cal clinics in Denmark covering a population of 2.7
million people corresponding to 47% of the Danish
population.
Initially, a total of 629 patients were identiﬁed in the
operation planning system ORBIT with a procedural
code for ventriculoperitoneal-shunt (KAAF05) or
ventriculoatrial-shunt (KAAF15) surgery. The inclusion
and exclusion of patients is shown in ﬁgure 1. Only
patients with a primary shunt insertion were included.
For all patients the information shown in box 1 was
entered into a database.
Definitions and classification
The following deﬁnitions and classiﬁcations were to a
large extent adapted from the 1958 to 1989 cohort by
Borgbjerg et al.2–4
Diagnosis: Patients younger than 1 year of age were
categorised as having (1) congenital hydrocephalus
(shunt insertion within 4 weeks postnatal) or (2) infant-
ile hydrocephalus (shunt insertion within the ﬁrst year).
Hydrocephalus in patients 1 year of age or older was
deﬁned as acquired hydrocephalus and divided into (3)
high-pressure hydrocephalus and (4) normal-pressure
hydrocephalus. Patients with a demonstrated aqueductal
stenosis were classiﬁed as (5) aqueductal stenosis regard-
less of age. In 10 cases, the information in the medical
record was inadequate or the symptoms of the patient
and diagnostic tests too divergent to ﬁt into a diagnostic
category. These patients were classiﬁed as (6) others.
Glasgow Coma Scale (GCS): Severity of brain injury
before insertion was measured as GCS and divided into
three groups: (1) GCS 14–15: mild or no injury (2) GCS
9–13: moderate injury (3) GCS 3–8: severe injury.
Surgeon: Three subgroups according to the surgeon’s
level of education were deﬁned: A registrar was the
youngest surgeon and not yet in a neurosurgical training
programme. A trainee was a doctor in a neurosurgical
training programme. The neurosurgeon was the most
experienced and a specialist in neurosurgery.
Duration: Operations were divided into four groups
according to the duration of surgery: (1) <30 min (2)
30–59 min (3) 60–89 min and (4) 90 min or more.
Time of day: Time of surgery was classiﬁed as day
(08:01 to 16:00.), evening (16:01 to 12:00.), or night
(00:01 to 08:00).
Antibiotics: In contrast to the historical study period,2 it
was standard routine to administer antibiotic prophylaxis
intraoperatively.
Figure 1 Flow chart presenting the inclusion and exclusion
of patients. Reading the operative reports revealed that 23
patients did not undergo a CSF shunt procedure. A total of
168 patients were excluded because of previous shunt
surgery and 4 patients were excluded because no follow-up
information was available leaving 434 patients in the study.
CSF, cerebrospinal fluid; VA-shunt, ventriculoatrial-shunt;
VP-shunt, ventriculoperitoneal-shunt.
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Surgical ﬁndings: Only the ﬁrst revision deﬁned as the
ﬁrst shunt failure needing surgical intervention was
included. We distinguished between: (1) proximal
defect or obstruction; (2) proximal displacement; (3)
distal defect or obstruction; (4) distal displacement; (5)
valve defect; (6) over drainage; (7) acute infection
(symptoms within 4 weeks after insertion); (8) late infec-
tion (symptoms later than postoperative week 4); (9)
risk of infection/skin defect with exposed hardware;
(10) no abnormal ﬁndings (despite clinical evidence of
shunt failure, the entire system was found functioning
intraoperative); and (11) others. Infection was deﬁned
according to the literature as clinical signs of peritonitis,
septicaemia, meningitis or wound infection and bio-
chemical or microbiological ﬁndings consistent with
infection.2 9
Statistical procedures
Most data were categorical and analysed using χ2 tests
reported with p values ≤0.05 as the level of signiﬁcance.
All conﬁdent intervals reported were 95% limits. In
some cases, the χ2 test criteria were met by combining
categories. In the case of antibiotic prophylaxis and risk
of infection this was not possible; instead logistic regres-
sion was used in the analysis. In the case of ordered vari-
ables, when useful, the χ2 test was supplemented with
the Mantel-Haenszel test for trend used as a more
powerful test against a more restricted null hypothesis.23
Logistic regression was used to compare numerical
variables on outcome variables and multiple logistic
regression was used to determine independent risk
factors for infection.
The Kaplan-Meier method of survival analysis was
used to investigate shunt survival time including Log
Rank test to test for the inﬂuence on survival time of sig-
niﬁcant risk factors. To transfer the Kaplan-Meier plot
by Borgbjerg et al4 into a new graph, the software
package Engauge Digitizer was used.
Statistical software packages used were IBM SPSS
Statistics V.22 and R V.3.1.3.
RESULTS
Patient demographics and characteristics
Patient demographics and characteristics are shown in
table 1. The age distribution of included patients is
shown in ﬁgure 2; mean age was 54.4 years (median
61.0 years; range 0–94) at the time of insertion.
Mean follow-up time was 1.71 years (median 1.53;
range 0.00–4.94). 99 patients died within 2 years after
insertion of which 35 had a revision. Further eight
patients were censored in the follow-up period, six
because of dead more than 2 years after insertion, 2
because of emigration. No deaths were related solely to
shunt surgery but rather underlying diseases (eg, neo-
plasms, haemorrhages, trauma and for the older NPH
patients also comorbidity).
The most common diagnosis was high-pressure hydro-
cephalus including 267 (61.5%) patients. In recognition
of the diversity in this large group, we further subdivided
this group based on aetiology of hydrocephalus.
For 24 children the severity of brain injury was not
measured or was inadequately described.
The majority of surgeries, that is 353 (81.9%), were
performed with ﬁve to six people in the operating
room. The intraoperative documentation was missing in
three cases.
Most patients either received antibiotic prophylaxis
intraoperatively or were already receiving antibiotics at
the time of insertion. In 44 (10.1%) procedures antibio-
tics were by inscrutable reasons not administered.
Rate of revision and risk factors
Overall, 185 (42.6%) patients had at least one revision
(table 2). The majority of revisions (65.4%) occurred
within 6 months after shunt surgery. However, the mean
time to ﬁrst revision was 7.51 months reﬂecting that the
main impact is made by early revisions, and late revisions
only inﬂuence modestly. The following factors—experi-
ence of the surgeon (p 0.286), duration of surgery (p
0.467), time of day (p 0.482), and number of people in
the operating room (p 0.416)—were not found to inﬂu-
ence the rate of revision signiﬁcantly.
Age of the patient was a signiﬁcant risk factor for revi-
sion (p 0.005) with the highest rate among patients
younger than 1 year of age at the time of shunt surgery.
For patients younger than 15 years of age (n=22+22=44)
the rate of revision was 63.6% vs 40.3% in adults (p
0.005). As expected, the trend was signiﬁcant (p 0.001),
with lower risk of revision with increasing age.
Subgroup analysis for ‘diagnosis’ was not possible
because too few patients had a revision to meet the
Box 1 Information entered into Database
Patient specific information
▸ date of birth
Information related to shunt insertion
▸ age at insertion
▸ distal shunt catheter placement
▸ diagnosis
▸ severity of brain injury
▸ surgeon’s educational level
▸ duration of surgery
▸ time of surgery
▸ number of people in operating room
▸ antibiotic prophylaxis
Information related to first revision
▸ date of revision
▸ operational findings
Follow-up information
▸ date of lost to follow-up
▸ cause of lost to follow-up
Information was extracted from the medical records, operative
reports, clinical image (MR and CTC) descriptions, and intrao-
perative documentation.
Cause of lost to follow-up was either dead or emigration.
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criteria for the χ2 test. By deﬁning a low-risk and high-
risk diagnosis group, a higher risk of revision (p 0.037)
among patients with congenital hydrocephalus, infantile
hydrocephalus and aqueductal stenosis was revealed.
The effect of severity of brain injury had a signiﬁcant
inﬂuence on risk of revision with the trend being the
more severe brain injury, the lower rate of revision (p
0.018). However, a test of pairwise risk difference
showed that the risk of revision was only signiﬁcantly dif-
ferent from each other between the groups GCS 14–15
and GCS 9–13 (p 0.009).
Rate of infection and risk factors
The majority of shunt-related infections (58.3%) fell
within the ﬁrst four postoperative weeks. Fourteen
(3.2%) patients had an acute infection and overall,
Table 1 Demographics and characteristics of patients
Total patients n=434
n Per cent n Per cent
Age group (years) Level of brain injury
<1 22 5.1 GCS 14–15 251 61.2
1–14 22 5.1 GCS 9–13 116 28.3
≥15 390 89.9 GCS 3–8 43 10.5
Distal placement Missing 24
Atrial 4 0.9 Surgeon
Peritoneal 430 99.1 Registrar 105 24.2
Diagnosis Trainee 131 30.2
Congenital 4 0.9 Neurosurgeon 198 45.6
Infantile 16 3.7 Duration (min)
NPH 126 29.0 <30 74 17.1
HPH 267 61.5 30–59 284 65.4
Posthaemorrhagic 150 60–89 67 15.4
Space-occupying lesions 67 ≥90 9 2.1
Post-traumatic 25 Time
IIH 14 Day 282 65.0
Postinfectious 3 Evening 140 32.3
Juvenile 7 Night 12 2.8
Others 1 AB prophylaxis
Stenosis 11 2.5 Yes 328 75.6
Other 10 2.3 No 44 10.1
In treatment 62 14.3
The seven categories of HPH aetiology are italicized. Space-occupying lesions include 59 patients with malignant brain tumours, 4 patients
with benign intraventricular cysts and 4 patients with giant basilar aneurisms. IIH=idiopathic intracranial hypertension. Postinfectious include
patients with hydrocephalus secondary to meningitis. Juvenile include children with a demonstrated increased intracranial pressure without
any structural pathology on MRI. One patient did not fit into any of these categories.
AB prophylaxis, whether the patient receives antibiotic prophylaxis intraoperatively or is in a covering treatment; HPH, high-pressure
hydrocephalus; NPH, normal-pressure hydrocephalus; Stenosis, aqueductal stenosis.
Figure 2 Histogram showing the
age distribution of patients at the
time of primary shunt insertion.
The bimodal distribution with a
sharp peak <1 year of age and a
broad peak covering the ages
48–80 years illustrates the
occurrence of infantile
hydrocephalus versus the
dominance of NPH in the senior
population. The low occurrence in
the interim decades mainly
contains cases with
hydrocephalus related to other
diseases; for example, SAH,
tumours and trauma. NPH,
normal-pressure hydrocephalus;
SAH, subarchnoid haemorrhage.
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24 (5.5%) patients had an infection (table 3). In con-
trast to other studies, in our study our rate of infection
was not inﬂuenced signiﬁcantly by age. Among the 44
patients younger than 15 years of age no one had an
infection at all (0.0%), hence all 24 patients with infec-
tion were adults (6.2%), but the numbers (22 below
1 year and 22 between 1 and 14 years) were too small for
comparison (p 0.289); for example, just one case of
infection in one of these groups would have changed
the rate from 0 to 4.5%. Other factors without signiﬁ-
cant inﬂuence on infection risk were low-risk or high-
risk diagnosis group (p 0.243), severity of brain injury
(p 0.492) or time of day for the surgery (p 0.272).
Owing to the low number of patients with infection,
some risk factor variables were combined for the ana-
lysis. Surgeons were said to be non-specialists if they are
registrars or trainees. A lower risk of acute infection (p
0.002) was observed among non-specialists (0.8%) than
among neurosurgeons (6.1%).
The duration of surgery was combined in only two cat-
egories: short duration if <60 min and long duration if
60 min or more. The risk of acute infection (p 0.022) as
well as overall infection (p 0.050) was lower if surgery
was performed in <60 min.
The effect of antibiotic prophylaxis was analysed using
logistic regression. The categories (1) already receiving
antibiotic and (2) antibiotic prophylaxis were combined
in one group and compared to (3) no antibiotic prophy-
laxis. The odds of an acute infection were 5.43 times
higher (p 0.004, table 4) with no antibiotic prophylaxis.
The odds for an infection at any time was 5.19 (p
<0.001) times higher without antibiotics.
Table 2 Significant risk factors for shunt revision
Rate of revision 185/434=42.6% (CI 38.0 to 47.3)
Number with revision
p Value χ2 p Value trendRisk factor n % (CI)
Age group (years)
<1 16 72.7 (54.1 to 91.3) 0.005 0.001
1–14 12 54.5 (33.7 to 75.4)
≥15 157 40.3 (35.4 to 45.1)
Diagnosis group
Con+Inf+Stenosis 19 61.3 (44.1 to 78.4) 0.037 −
NPH+HPH+Others 166 41.2 (36.4 to 46.0)
Level of brain injury
GCS 14-15 116 46.2 (40.0 to 52.4) 0.016 0.018
GCS 9-13 36 31.0 (22.6 to 39.5)
GCS 3-8 15 34.9 (20.6 to 49.1)
High-risk diagnosis group=congenital+infantile+aqueductal stenosis.
Low-risk diagnosis group=normal-pressure hydrocephalus+high-pressure hydrocephalus+others.
Only significant risk factors for shunt revision are included in this table. Mantel-Haenszel test for trend is used as a supplement in the analysis
of ordered variables with more than two categories.
Revision rates for the subgroups of HPH-patients based on aetiology are presented in online supplementary table SA.
GCS, Glasgow Coma Scale; HPH, high-pressure hydrocephalus; NPH, normal-pressure hydrocephalus.
Table 3 Significant risk factors for shunt infection
Rate of acute infection 14/434=3.2% (CI 1.6 to 4.9)
Rate of infection 24/434=5.5% (CI 3.4 to 7.7)
Number with acute infection Number with infection
Risk factor n Per cent (CI) p Value χ2 n Per cent (CI) p Value χ2
Surgeon group
Non-specialist 2 0.8 (0 to 2.0) 0.002 9 3.8 (1.4 to 6.3) 0.096
Neurosurgeon 12 6.1 (2.7 to 9.4) 15 7.6 (3.6 to 11.3)
Duration
Short <60 min 8 2.2 (0.7 to 3.8) 0.022 16 4.5 (2.3 to 6.6) 0.050
Long ≥60 6 7.9 (1.8 to 14.0) 8 10.5 (3.6 to 17.4)
AB prophylaxis
Yes 8 2.4 (0.8 to 4.1) 0.012 15 4.6 (2.3 to 6.8) 0.001
No 5 11.4 (2.0 to 20.7) 8 18.2 (6.8 to 29.6)
In treatment 1 1.6 (0 to 4.7) 1 1.6 (0 to 4.7)
For p=0.012 and p=0.001 the χ2 test criteria were not met.
Only significant risk factors for acute infection or infection overall are included in this table. Valid and significant p values are in boldface.
Non-specialist=registrar+trainee.
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Surgery performed by neurosurgeons had an OR for
acute infection of 7.55 compared to non-specialists, this
was despite the fact that they performed surgery faster
than non-specialists (p <0.001). Surgeries of longer dur-
ation carried an OR of 3.75 compared to short surgeries
(table 4).
The number of people in operating room was not a
signiﬁcant predictor of acute infection, that is, OR 0.57
(p 0.124) (table 4).
Each risk factor was analysed controlling for the effect
of the others using multiple logistic regression (right
side of table 4). As shown, surgeon, duration and anti-
biotic prophylaxis were individual signiﬁcant predictors
of acute infection all with p values of 0.001.
Kaplan-Meier shunt survival
The overall shunt survival curve of our study is pre-
sented in ﬁgure 3 together with the previous survival
curve published in 1998.4 Mean survival time was
2.88 years (table 5). One and 5-year shunt survival
probabilities were both higher in our study, although a
test of signiﬁcant difference was not performed due to
the absence of raw data from the 1998 study.
We further looked for the inﬂuence on shunt survival
by other variables. Patients younger than 1 year of age
had a signiﬁcantly (p 0.004) poorer survival curve than
patients 15 years or older with no difference between
the two older age groups, table 5.
Patients belonging to the low-risk diagnosis group
appeared to have longer shunt survival though the dif-
ference was not signiﬁcant (p 0.069), table 5.
Survival curves for age groups and diagnosis groups
are presented in the online supplementary ﬁgures S1
and S2.
Surgical findings at first revision
In table 6, nine common causes of revision included in
both studies are presented with proportions of all revi-
sions (n=185) in our study. ‘Other causes’ artiﬁcially
appears to be the most frequent but is due to its cover-
ing of three of our original causes not included in the
previous study.3 Ignoring this, the most frequent cause
of revision in our study was valve defects accounting for
a signiﬁcantly larger proportion of all revisions com-
pared to the previous study (10.5% vs 18.4%, p 0.012).
Proximal defect or obstruction was the second most fre-
quent cause of revision (15.7%) with the subunit discon-
nection accounting for 17 (9.2%) revisions alone.
Among distal causes of revision, distal displacement
was the main problem with the subunit subcutaneous dis-
placement being the most frequent (7.6%). Distal defect
or obstruction had decreased signiﬁcantly as a cause of
revision compared to the previous study (p 0.003).
Comparison with previous study
The analysis of changes in signiﬁcant patient demo-
graphics and characteristics revealed that proportionally
more patients were adults in our study, which was also
reﬂected in the lower proportion of high-risk diagnoses.
More procedures were performed by registrars and
Table 4 Analysis of risk factors for acute infection—univariate and multivariate analyses
Risk factor
Logistic regression—effect of
single independent risk factor
Multiple logistic regression—effect
of each controlling for the others
OR CI for OR p Value OR CI for OR p Value
Surgeon group
Neurosurgeon vs Non-specialist 7.55 1.67 to 34.15 0.009 15.35 2.98 to 79.17 0.001
Duration
Long ≥60 min vs Short <60 min 3.75 1.26 to 11.14 0.017 8.20 2.34 to 28.79 0.001
People in operating room 0.57 0.28 to 1.17 0.124 0.64 0.31 to 1.30 0.22
AB prophylaxis
No AB vs AB+In treatment 5.43 1.73 to 17.00 0.004 8.45 2.30 to 31.11 0.001
AB prophylaxis: the odds of an acute infection in the subgroup of patients with no antibiotic prophylaxis are compared with the odds of an
acute infection in patients already receiving antibiotic or those who received antibiotic prophylaxis intraoperatively.
Non-specialist=registrar+trainee.
Significant risk factors for acute infection in addition to number of people in operating room are analysed with logistic regression. Significant
p values are in boldface.
Figure 3 Kaplan-Meier plot of previous and present study
showing the revision free shunt durability for all patients,
n=884 and n=434 respectively. Note the difference in
follow-up time resulting in disruption of the solid curve by
time=4.94 years (maximum follow-up time in our study). With
permission of Springer.4
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trainees in our study and in general, the procedures
were performed faster; for speciﬁcation see online
supplementary table SB.
Data used in the analysis of any development since the
1958–1989 cohort, are presented in table 7 and reported
as risk differences. The rate of revision of primary
shunt surgery had not decreased signiﬁcantly since the
previous study period (p 0.060). This is in accordance
with the only slightly different shunt-survival curves
(ﬁgure 3) and the overlapping CIs for 5-year shunt sur-
vival (table 5). The insigniﬁcant trend towards lower risk
of revision and longer shunt survival should be seen in
the context of changed patients’ demographics and risk
factors.
As expected, the rate of acute infection had decreased
signiﬁcantly (p 0.037) but nonetheless the rate
of overall infection had not decreased signiﬁcantly
(p 0.261).
DISCUSSION
In this study we retrospectively presented data on shunt
operated patients during the period 2010–2012 and
compared this data to our own historical data collected
40 years ago. Overall, our study conﬁrms some well-
documented risk factors for revision and infection. In
addition, we had the opportunity to describe the devel-
opment of shunt surgery at our department through the
past four decades.
Rate of revision and shunt survival
In our study the overall rate of revision was signiﬁcantly
higher among children (63.6%) than adults (40.3%).
Most revisions occurred within 6 months in accordance
with the literature.4 8 24
Not surprisingly, we found the rate of revision to be
dependent on age and diagnosis as reported by
others.7 11 Studies including both adults and children
have reported rates of revision in the same range (23–
46%)7 10 12 as in our study. In studies including only
adults, rates of revision has been reported to be 14–
32%.5 24 In studies including only children, Berry et al11
found a revision rate of 37% and Stone et al8 found that
84.5% had a revision in their long-term follow-up study.
The probability of 1 year shunt survival in our study was
66.2%. In comparison, Hanlo et al12 and Cochrane and
Kestle25 have reported 1-year shunt survival probabilities
Table 5 Kaplan-Meier analysis
Study or risk factor
Mean survival time
year (CI)
1-year survival
Per cent (CI)
5-year survival
Per cent (CI) Log rank p Value
Study
Present study 2010–2012 2.88 (2.66 to 3.10) 66.2 (61.5 to 70.9) 48.0 (41.1 to 54.9) –
Previous study 1958–1989 – 57 (53 to 61) 37 (32 to 42)
Age group (years)
<1 1.50 (0.85 to 2.15) 52.6 (31.2 to 74.0) 0.004
1–14 2.27 (1.32 to 3.22) 52.9 (31.5 to 74.3)
≥15 2.98 (2.75 to 3.22) 67.9 (63.0 to 72.8)
Diagnosis group
Con+Inf+Stenosis 1.98 (1.35 to 2.61) 60.1 (42.7 to 77.5) 0.069
NPH+HPH+Others 2.94 (2.71 to 3.17) 66.8 (61.9 to 71.7)
Comparison of shunt survival in previous and present study—survival curves are shown in figure 3. Log Rank test is used to test for a
significant influence on shunt survival of age group and diagnosis group in the present study.
p, 0.004 between <1 year and ≥15 years; p, 0.320 between <1 year and 1–14 years; p, 0.262 between 1–14 years and ≥15 years.
Time, 4.94 years is used to estimate the 5-year shunt survival in our study.
HPH, high-pressure hydrocephalus; NPH, normal-pressure hydrocephalus.
Table 6 Surgical findings at first revision
Cause of revision n=185 Per cent p Value
Proximal defect or
obstruction
29 15.7 0.169
Obstruction 12 6.5
Disconnection 17 9.2
Proximal displacement 17 9.2 0.657
Distal defect or
obstruction
7 3.8 ↓ 0.003
Distal displacement 20 10.8 0.301
Subcutaneous 14 7.6
Radiating pain 6 3.2
Valve defect 34 18.4 ↑ 0.012
Acute infection 14 7.6 0.090
Late infection 10 5.4 0.128
No abnormal findings 4 2.2 0.984
Others 50 27.0 ↑ 0.005
Over drainage 24 13.0
Risk of infection/
wound
7 3.8
Others 19 10.3
Proportion of all causes in present study increased (↑) or
decreased (↓) compared to the previous study with corresponding
p values for significant difference. Significant p values are en
boldface.
The 19 causes classified as Others include: change to a different
valve (6); shunt insertion into infected CSF (2); postoperative
haemorrhage (2); haemorrhage not related to shunt (3); additional
ventricle catheter (1); suspected infection without evidence (1);
withdrawal (1); abdominal hernia (1); operational error (1); no
description (1).
CSF, cerebrospinal fluid.
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of 71% and 59%, respectively, and Reddy et al7 reported
signiﬁcantly shorter shunt survival in paediatric patients
consistent with our ﬁndings.
The lower rate of revision observed among patients
with more severe brain injury is most likely the result of
these patients’ shorter survival time and inability to
report symptoms of shunt failure.
Discrepancies in reported rates of revision among
studies are probably a combined result of actual differ-
ences and different study designs including differences
in follow-up time and patients demographics, for
example, the age composition would inﬂuence the
results signiﬁcantly. Another challenge of comparing
revision rates is the inﬂuence of different aetiologies
that has been shown to be signiﬁcantly associated with
shunt revisions.5 7 26 27
Only few studies have considered whether the
improvement in materials and techniques through the
past few decades has resulted in better outcomes for
shunt treated patients. Compared to the previous study
from our department, the difference in revision rates
from 48.3% to 42.6% was not statistically signiﬁcant. The
changed demographics with fewer children and fewer
high-risk diagnoses in our study may have caused a
reduction itself.
Molina et al19 and Drake et al21 reported that new
shunt systems were not better than old systems and a
review by Stein et al20 showed no improvement in revi-
sion rates over the past few decades. In contrast,
Kulkarni et al22 compared two cohorts of paediatric
patients with primary shut surgery in 1993–1999 and
2008–2012, respectively, and found a signiﬁcantly longer
shunt survival for the 2008–2012 cohort.
While study conclusions regarding positive develop-
ment or not are based mainly on the presence of signiﬁ-
cant p values, which depends highly on study design and
patient volume, the overall trend seems to be a lack of
convincing improvement in shunt surgery. This absence
of improvement consistent with our results must be com-
pared to the development of other surgical procedures.
For example, the 10-year revision free probability of total
hip replacements has increased from about 85% in 1979
to about 95% for procedures performed in 2004 accord-
ing to The Swedish Hip Arthroplasty Register’s annual
report 201328 and Herberts and Malchau.29 Similar
development has been reported by cardiologists per-
forming heart valve replacements. Hokken et al30
reported a lower risk of early mortality following aortic
heart valve replacement, that is, OR=0.2 for procedures
performed in 1990 vs 1970 despite increased proportion
of high-risk patients. Similar developments are reported
by Feyrer et al31 and The Society of Cardiothoracic
Surgeons of Great Britain and Ireland.32
One important consideration to make is whether
decreasing the rate of shunt revision is the right
measure of success as indicated by Di Rocco et al.33
Since the overall objective is to achieve a better treat-
ment for patients with hydrocephalus, the introduction
of new surgical procedures for patients with hydroceph-
alus such as third ventriculostomy can result in a persist-
ently high rate of revisions among shunt-treated
patients, however, with better outcomes for the total
group of patients with hydrocephalus.
To point out reasons for the lack of improvement is
beyond the scope of this study, but a rapid implementa-
tion and ongoing evaluation of new techniques, shunt
materials and individualised treatment strategies may be
a part of the solution. According to Herberts and
Malchau,29 the ongoing evaluation of best practices and
implants provided by The Swedish Hip Arthroplasty
Register has been a major contributor to the develop-
ment seen in Sweden. The same position is advocated by
Larsson et al34 who argue that the implementation of
disease registries has the possibility to lower health costs
due to fewer reoperations and complications. So far,
there are no publications from shunt registries
Table 7 Comparison of previous and present study
Previous study
1958–1989, %
Present study
2010–2012, % Risk difference % (CI) p Value
Revision 48.3 42.6 −5.7 (−11.5 to 0.20) 0.060
Before 1970 58.4 −15.8 (−25.4 to −6.1) 0.001
1970–79 54.6 −12.0 (−19.3 to −4.6) 0.001
1980–89 33.7 9.0 (2.1 to 15.8) 0.010
Infection 7.4 5.5 (4.1*) −1.8 (−4.7 to 1.1) 0.261 (0.039*)
Before 1970 2.7 2.8 (−1.0 to 6.7) 0.238
1970–79 8.6 −3.1 (−7.0 to 0.9) 0.126
1980–89 8.0 −2.5 (−6.2 to 1.2) 0.192
Acute infection 6.1 3.2 −2.9 (−5.3 to −0.42) 0.037
Pairwise comparison of the proportions is reported as risk difference with related p values indicating significant difference or not.
*To estimate the effect of antibiotic prophylaxis, all patients in present study with no antibiotic prophylaxis (n=44) were excluded resulting in a
significant difference (p 0.039) in risk of infection for all patients who followed the current regimen.
As well as comparing the 2010–2012 cohort with the entire 1958–1989 cohort, the new cohort is compared to three individual time periods in
the previous study and presented in the table in italics. The rate of revision was significantly higher (p 0.001) in the first two time periods
compared to the 2010–2012 cohort, but it was significantly lower in the latest decade (p 0.010). Though the rate of infection was remarkably
lower in the earliest time period, compared to the 2010–2012 cohort none of the three time periods had a significantly different rate of
infection.
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demonstrating a similar complication reducing effect on
shunt surgery.
Infection and antibiotic prophylaxis
Postoperative shunt-related infections have been consid-
ered a major problem of shunt surgery due to its signiﬁ-
cant consequences for the patient and as a complication
costly to treat. Despite the positive development in tech-
niques and procedures to prevent infection through the
past few decades, the problem still deserves our attention.
Overall, 24 (5.5%) patients in our study had an infec-
tion of which 14 (3.2%) fell within 4 weeks postopera-
tively. This is in the lower range of others published
ﬁndings, which may be inﬂuenced by the fact that we
included only primary shunt insertions into our study
and revision procedures have been shown to have a
higher rate of infection.10 35 The rate of revision was
6.2% for adults and 0.0% for children. Studies including
both adults and children and primary insertions as well
as revisions have reported per procedure infection rates
of 6.1%, 7.2% and 8.3%.9 10 12 For paediatric patients
per procedure infection rates have been reported by
Piatt et al6 who found 2.0% to have an infection within
30 days postoperatively and Cochrane and Kestle25
found 8.6% to have an infection. A signiﬁcantly lower
risk of acute infection was observed compared to the
previous study from our department.2 The reduction of
overall infection risk was not signiﬁcant.
In accordance with other studies we found the infec-
tion rate to depend on antibiotic prophylaxis, duration
of surgery,10 and the risk of acute infection further
depended on the surgeon’s experience.
In 1995 Borgbjerg et al2 concluded that intraoperative
antibiotic prophylaxis was still controversial. We found
the OR for infection without the use of antibiotics to be
as high as 8.45 for acute infection and 6.18 for infection
overall, that is, antibiotics have a greater effect on acute
infection. In comparison, large meta-analytic publica-
tions report an OR for overall infection of ∼2 by the use
of antibiotics.36 37 This indicates that other patient-
related and surgery-related factors than antibiotic
prophylaxis may account for the difference in infection
OR between our studies and other studies, but our data
do not permit us to deﬁne these.
Efforts to further reduce the infection risk include the
application of strict protocols including all known risk
factors. Choux et al38 and Kestle et al39 have reported
admirable results by the application of relatively simple
protocols including focus on prophylaxis, signs on the
door to reduce trafﬁc, focus on hand scrub, few people
in the operating room etc to reduce infection risk in
children. Prospective studies evaluating such protocols
under different settings are needed.
The theory behind the association of number of per-
sonnel in the operating room and infection is based on
correlation between number of persons and air contam-
ination.40 Reducing the number of people has been part
of successful protocols to reduce infection.38 It should
be mentioned that a lot of contributing factors to air
contamination were not measured, for example, level of
conversation and trafﬁc in the room. Additionally, only
very few operations were performed with more than six
people making it difﬁcult to detect any contribution to
infection risk.
Surgeon’s experience has been deﬁned in different
ways. For example, Cochrane and Kestle41 found the
number of procedures performed by each surgeon in
the study period to inﬂuence infection rate with more
experienced surgeons having lower risk of infection. In
contrast, we found that non-specialists—the more inex-
perienced surgeons who performed surgery slower—had
a lower rate of acute infection than the neurosurgeons,
which is also the opposite of what Borgbjerg et al2
reported. This indicates that procedure routine rather
than ‘rank’ of the surgeon might be a better measure
for surgical skills and several underlying confounders
must have inﬂuenced our result.
Causes of revision
Knowledge about the most frequent causes of shunt
failure is a prerequisite for targeting the effort to reduce
revisions. In our study the most frequent causes of revi-
sion were valve defects (18.4%), proximal defect or
obstruction (15.7%) including disconnection (9.2%),
over drainage (13.0%), distal displacement (10.8%) and
proximal displacement (9.2%). Similar results reported
by other authors may have been inﬂuenced by variation
in classiﬁcation of causes, demographic factors like age,
diagnoses and aetiology and whether revisions proce-
dures were included for analysis. By recalculating the
results, three studies,8 10 12 all including revisions,
reported proximal obstruction to constitute 14–27% of
all revisions, disconnection 1.5–11%, valve defect 8–
18.4% and two studies10 12 reported over drainage to
constitute 5.1–11% of revisions.
Compared to the 1958–1989 cohort,3 valve defects
constitute a signiﬁcantly higher proportion of revision
causes while distal defects and obstructions constitute a
signiﬁcantly smaller proportion.
Several studies have investigated speciﬁc actions to
reduce individual failures. Proximal obstruction is a per-
sistent challenge in shunt surgery. The importance of
accurate proximal catheter placement to reduce prox-
imal obstruction has been described by Janson et al14
and several authors have reported beneﬁcial effect of
the use of intraoperative imaging in the accuracy of
proximal catheter placement and proximal shunt failure
rates, though some of these studies fail to improve
overall shunt failure rate.14 15 42 43 Prospective studies
applying known strategies to reduce speciﬁc complica-
tions in high-risk patients are desired in the develop-
ment towards more patient-speciﬁc treatments.
Limitations
Owing to its retrospective design this study has several
limitations. Decision-making about shunt insertion and
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revision was inﬂuenced by individual surgeons. Some of
the clinical variables were not described in a standar-
dised way, but were extracted from surgical notes and
charts. Furthermore, some variables were not included
for analysis, for example, valve type and aetiology was
only considered for the patients with high-pressure
hydrocephalus.
Despite the limitations, the retrospective design has
the opportunity to analyse how shunt treatment has
evolved over decades in a large patient sample contribut-
ing to increased study power. The often limiting problem
of lost to follow-up is most likely reduced to a minimum
in our study because of the comprehensive national regis-
tration in Denmark of health data, death, emigration and
the electronic medical report including all contacts with
healthcare providers in a speciﬁc region which enables
us to follow all patients whether hospitalised or not.
CONCLUSIONS
This retrospective study reveals a substantial number of
patients experiencing shunt revisions following primary
shunt insertion. Though patient demographics have
changed with fewer children resulting in fewer high-risk
patients in the new 2010–2012 cohort, the rate of revi-
sion has not decreased through the past four decades
and remains above 40%. The odds of an acute infection
is 8.45 times higher without the use of antibiotic prophy-
laxis and the implementation of antibiotic prophylaxis
might be the most important contributor to the signiﬁ-
cant reduction in acute infection. The risk of overall
infection has not decreased signiﬁcantly.
Our ﬁndings ﬁt well with the current literature and at
the same time emphasise the need for improved techni-
ques, equipment and shunt materials to reduce the rate
of complications. Future prospective studies must
conﬁrm causal risk factors and further evaluate the ben-
eﬁts of applying a more patient-speciﬁc strategy to
reduce revision rates.
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